Ascendis Pharma A/S : Form 6-K -December 13, 2023 at 04:07 p

Ascendis Pharma A/S : Form 6-K -December 13, 2023 at 04:07 pm EST

Ascendis Pharma A/S










Name, Registered Office and Objects of the Company:


Article 1
...

Related Keywords

United States , District Of Columbia , Hellerup , Hovedstaden , Denmark , Cayman Islands , United Kingdom , Sweden , Switzerland , Netherlands , California , Luxembourg , New York , Ireland , Menlo Park , Palo Alto , Jersey , Copenhagen , Køavn , Bermuda , America , American , Kingdom Of Denmark , Republic Of Ireland , Danish , Ascendis Pharma Adss , Ascendis Pharmas , Markv Roeder , Joshua Hahn Ascendis Pharma , Johnc Williams , Ascendis Pharma , Computershareas Company , Exchange Offer Valuation Period , Company Optional Redemption , Company Ordinary , Us Bank Trust Company , Company Order , Exchange Commission , Evercore Group , Wells Fargo Securities , Company Prior To Maturity , Company Capital , Latham Watkins , Canaccord Genuity , Right Of The Company To Redeem , Federal Reserve Bank , Bloomberg , Danish Companies , Cantor Fitzgerald Co , Morgan Stanley Co , Valid Obligations Of The Company , Exchange Act , Credit Suisse Securities United States , Conversion Agent To Notify Company Of Conversions , Berenberg Capital Markets , Articles Of Association Ascendis Pharma , Us Trust Indenture , Ascendis Pharma Inc , Termination Of Company Obligations , Danish Business Authority , Business Day Of The Company , Termination Of The American Depositary Share Program , Significant Subsidiary Of The Company , National Association , Company Wholly Owned Subsidiaries , Company Right To Appoint Successor Registrars , No Sinking Fund , Capital Shares Of The Company , Exchange In Lieu Of Conversion , American Depositary Share Program , Group Inc , Medallion Program , Nasdaq , Kingdom Of Denmark The Company , Company Adss , Objects Of The Company , Company May , Company Significant Subsidiaries , Affiliate Of The Company , Subsidiary Of The Company , New York Stock Exchange , Remuneration Committee Of Ascendis Pharma , Repayment To Company , No Services , Us Securities Exchange , Exchange Rate , Jp Morgan Securities , Or Exchange , Us Internal Revenue Service , York Stock Exchange , Articles Of Association , Registered Office , Danish Companies Act , Executive Management , American Depositary , American Depositary Shares , Greater Copenhagen , Annual Report , Ordinary Shares , Remuneration Committee , Danish Act , General Meeting , Danish Business , Copenhagen Arbitration , Subsequent Warrants , Coming Exercise , First Coming Exercise Period , First Coming Exercise , Warrant Certificate , Shareholders Agreement , Ascendis Pharma Board , Convertible Senior Notes , Additional Notes , Defaulted Amounts , Payment Date , Business Day , Paying Agent , Conversion Agent , Hold Property , Certain Transfer Restrictions , Redemption Upon Fundamental Change , Optional Redemption , Transfer Restrictions , Certain Rights , Global Notes , Company Prior , Default Certificates , Usury Laws , Redeem Notes Upon , Fundamental Change , Depositary Share Program , Securities Issued Upon Conversion , Conversion Rate , Make Whole Fundamental Change , Ordinary Share Change Event , Company May Merge , Asset Transfers , Wholly Owned Subsidiaries , Past Defaults , Institute Suit , Receive Payment , Conversion Consideration , May File Proofs , Special Record Dates , Execute Supplemental Indentures , Conditions Precedent , Personal Liability , Jury Trial , Adverse Interpretation , Restricted Note Legend , Global Note Legend , Non Affiliate Legend , Trust Company , American Depositary Share , Deposit Agreement , Issue Date , Ordinary Share , Last Reported Sale Prices , Trading Days , Trading Day , Make Whole Fundamental Change Effective Date , Make Whole Fundamental , United States Code , Relevant Taxing Jurisdiction , New York City , Legending Deadline , Free Trade Date , Regular Record Date , Interest Payment Date , De Legending Deadline Date , Interest Payment , New York Mellon , Depository Trust Company , Global Note , Capital Shares , Distributed Property , Maturity Date , Last Original Issue Date , Securities Act , Restricted Note , Nasdaq Global Market , Nasdaq Global Select Market , Reference Property , Change Redemption , Redemption Upon Fundamental , Morgan Stanley , Suisse Securities , Cantor Fitzgerald , United States Internal Revenue Code , Original Issue , Purchase Agreement , Shoe Option , Initial Purchasers , Reported Sale , Last Reported Sale Price , Last Reported Sale , Whole Fundamental , Optional Redemption Notice , Provisional Redemption , Whole Fundamental Change Conversion , Exempted Fundamental Change ,

© 2025 Vimarsana